FAST NEWS: Antengene appoints Hansoh to commercialize myeloma drug
The latest: Antengene Corporation Ltd. (6996.HK) announced Friday it has entered into an exclusive collaboration agreement with Hansoh Pharmaceutical Group Co. Ltd. (3692.HK) for the commercialization of the relapse or…
FAST NEWS: Antengene Corporation Announces First Ever Revenue of $7.8 Million
The latest: Antengene Corp. Ltd. (6996.HK), a biopharmaceutical company, announced Thursday it expects revenue for the six months ended June 30 this year to range from 53 million yuan ($7.8…
RELATED ARTICLES
-
Hong Kong’s Café de Coral takes go-slow approach to Mainland dining market
0341.HK - Increasing losses prompt Zephyrm Bioscience to seek funds through IPO
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: U.S. Ratchets Up Strategic Tariffs
- CHINA BULLETIN: Fiscal Revenue, Land Sales Fall in April
- CHINA BULLETIN: Services, Trade Send Positive Signals
